2-deoxy-2-fluorogalactose has been researched along with Experimental Mammary Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aho, K; Bergman, J; Haaparanta, M; Kulmala, J; Paul, R; Reissell, A; Solin, O | 1 |
| Fukuda, H; Ishiwata, K; Itoh, J; Kameyama, M; Kawashima, K; Matsuzawa, T; Muraishi, K; Tada, M; Takahashi, T; Yamaguchi, K | 1 |
2 other study(ies) available for 2-deoxy-2-fluorogalactose and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Imaging of rats with mammary cancer with two 2-deoxy-2-[18F]fluoro-D-hexoses.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Fucose; Galactose; Mammary Neoplasms, Experimental; Radionuclide Imaging; Rats; Rats, Inbred Strains | 1989 |
2-Deoxy-2-[18F]fluoro-D-galactose as an in vivo tracer for imaging galactose metabolism in tumors with positron emission tomography.
Topics: Animals; Fluorine Radioisotopes; Fucose; Galactose; Liver Neoplasms, Experimental; Mammary Neoplasms, Experimental; Mice; Neoplasms, Experimental; Rats; Sarcoma, Yoshida; Tomography, Emission-Computed | 1989 |